Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXR1YY
|
||||
| Drug Name |
(S)-1-(1H-indol-4-yloxy)-3-((2S,4S)-4-(4-methoxybenzo[b]thiophen-2-yl)-2-methylpiperidin-1-yl)propan-2-ol
|
||||
| Synonyms |
CHEMBL310883
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H30N2O3S
|
||||
| Canonical SMILES |
COc1cccc2sc(cc12)[C@H]3CCN(C[C@H](O)COc4cccc5[nH]ccc45)[C@@H](C)C3
|
||||
| InChI |
InChI=1S/C26H30N2O3S/c1-17-13-18(26-14-21-23(30-2)6-4-8-25(21)32-26)10-12-28(17)15-19(29)16-31-24-7-3-5-22-20(24)9-11-27-22/h3-9,11,14,17-19,27,29H,10,12-13,15-16H2,1-2H3/t17-,18-,19-/m0/s1
|
||||
| InChIKey |
CBTPCFLJYTWCHA-FHWLQOOXSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.